Skip to main content

and
  1. Article

    Open Access

    Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

    It has been reported that pathological complete response is an important surrogate marker for disease-free survival and overall survival in patients with triple-negative breast cancer. This study investigates ...

    Paul Gass, Michael P. Lux, Claudia Rauh, Alexander Hein, Mayada R. Bani in BMC Cancer (2018)

  2. Article

    Open Access

    DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer

    Identifying molecular alterations in normal tissue adjacent to cancer is important for understanding cancer aetiology and designing preventive measures. Here we analyse the DNA methylome of 569 breast tissue s...

    Andrew E Teschendorff, Yang Gao, Allison Jones, Matthias Ruebner in Nature Communications (2016)

  3. Article

    Open Access

    Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology

    Early detection of loco-regional breast cancer recurrence improves patients’ overall survival, as treatment can be initiated or active treatment can be changed. If a suspicious lymph node is diagnosed during a...

    Matthias Hammon, Peter Dankerl, Rolf Janka, David L. Wachter in BMC Women's Health (2015)

  4. No Access

    Article

    HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics

    Gene amplification is an important factor for altered gene expression in breast cancers. TOP2A-amplification often occurs concomitantly with HER2 amplification, and it has been suggested to be predictive for the ...

    Peter A. Fasching, Sebastian Weihbrecht in Breast Cancer Research and Treatment (2014)

  5. No Access

    Article

    Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis

    Prediction of the prognosis for metastatic breast cancer patients depends on molecular subtypes similar to those found in patients with primary breast cancer. Several studies have shown that estrogen receptor ...

    Christian R. Loehberg, Katrin Almstedt in Breast Cancer Research and Treatment (2013)

  6. Article

    Open Access

    Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval

    New anticancer treatments have increased survival rates for cancer patients, but often at the cost of sterility. Several strategies are currently available for preserving fertility. However, the chances of ach...

    Ralf Dittrich, Laura Lotz, Andreas Mueller in Reproductive Biology and Endocrinology (2013)

  7. No Access

    Article

    Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients

    Identifying biomarkers that can predict the prognosis and treatment response is helpful for individualizing breast cancer (BC) therapy. A neoadjuvant treatment setting is ideal for testing biomarkers capable o...

    David L. Wachter, Peter A. Fasching in Archives of Gynecology and Obstetrics (2013)

  8. No Access

    Article

    Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer

    There is growing evidence that certain breast cancer (BC) risk factors specifically increase the risk for specific molecular tumor subtypes. Different molecular subtypes of BC can partly be described by analyz...

    Katharina Heusinger, Sebastian M. Jud in Breast Cancer Research and Treatment (2012)

  9. Article

    Open Access

    Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

    The pathological complete response (pCR) after neoadjuvant chemotherapy is a surrogate marker for a favorable prognosis in breast cancer patients. Factors capable of predicting a pCR, such as the proliferation...

    Peter A Fasching, Katharina Heusinger, Lothar Haeberle, Melitta Niklos in BMC Cancer (2011)

  10. No Access

    Article

    Diabetes and prognosis in a breast cancer cohort

    Epidemiological studies indicated that type 2 diabetes mellitus may increase breast cancer risk and mortality. The aim of this retrospective cohort study was to examine the effect of diabetes on the clinical c...

    Michael G. Schrauder, Peter A. Fasching in Journal of Cancer Research and Clinical On… (2011)

  11. No Access

    Article

    Adenomatoid tumors of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specific morphologic diversity

    Adenomatoid tumors (ATs) are uncommon benign mesothelial tumors with a predilection for the genital tract. We reviewed 47 ATs diagnosed at our institutions during 10-year period. Thirty tumors (64%) originated...

    David L. Wachter, Peter H. Wünsch, Arndt Hartmann, Abbas Agaimy in Virchows Archiv (2011)

  12. No Access

    Article

    Impaired cell fusion and differentiation in placentae from patients with intrauterine growth restriction correlate with reduced levels of HERV envelope genes

    One leading cause of perinatal morbidity and mortality is intrauterine growth restriction (IUGR). Several causes for IUGR have been proposed involving cytotrophoblast dysfunction. Envelope genes of the human e...

    Matthias Ruebner, Pamela L. Strissel, Manuela Langbein in Journal of Molecular Medicine (2010)